Medical News

RSS

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

20 Oct 2009

Springer to launch "Translational Stroke Research" journal

Springer is launching a new quarterly journal Translational Stroke Research, which aims to help translate scientific discoveries from basic stroke research into the development of new strategies for prevention, assessment, treatment and repair after stroke and other forms of neurotrauma. The first issue will appear in March 2010.

20 Oct 2009

Age, gender and malignancies pose significant risk factors for TIVADs survival

It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems; however, risk factors impacting the survival of TIVADs remain unclear.

20 Oct 2009

Unemployment for people with disabilities has reached its highest rate since January, says study

Unemployment for people with disabilities has reached its highest rate since January, according to a quarterly study by Allsup, a nationwide provider of Social Security disability representation and Medicare services.

20 Oct 2009

ECRI Institute reports increase in request for medical technology acquisition support from its members

ECRI Institute(R), an independent nonprofit that researches the best approaches to improve patient care and offers procurement support to more than 2,000 U.S. hospitals, reports a significant increase in requests by its members for medical technology acquisition support, a strong signal that the economy may be improving. ECRI Institute member hospital research requests typically precede medical capital technology purchases.

20 Oct 2009

Academic medical centers do not always practice the values they preach

As the national conversation about healthcare reform engages millions of Americans, a new Brandeis study sheds light on the values of medical faculty who train the nation's physicians and lead in health care and research in the U.S.

20 Oct 2009

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.

20 Oct 2009

OHA announces its selection as one of Greater Toronto's Top 90 Employers for 2010

The Ontario Hospital Association (OHA) is pleased to announce that it has been recognized as one of Greater Toronto's Top 90 Employers for 2010.

20 Oct 2009

Higher status positions can have negative impact on personal health

Being at the top has its perks, but new UofT research shows people in positions of authority at work are more likely to experience certain psychological and physical problems that can undermine the health benefits associated with job authority.

20 Oct 2009

Study explores the link between LUTS and depression, anxiety disorders, sexual trauma

Depression, anxiety disorders and sexual trauma have all been implicated as risk factors in lower urinary tract symptoms (LUTS) such as incontinence and overactive bladder.

20 Oct 2009

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

AstraZeneca and POZEN Inc. today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology (ACR) 2009 Annual Scientific Meeting in Philadelphia, PA.

20 Oct 2009

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

20 Oct 2009

UHC selects RGIS to streamline inventory counting services

The University HealthSystem Consortium (UHC) today announced that it has awarded a 3-year agreement to RGIS, based in Auburn Hills, Mich, for inventory counting services. The agreement, which has 2 automatic 1-year renewal periods, became effective on September 1, 2009.

20 Oct 2009

Benefit Express collaborates with National Student Clearinghouse for student status verification services

Benefit Express, a Benefit Administration Outsourcing service provider, has partnered with National Student Clearinghouse® to allow My Benefit Express(TM) subscribers to validate full-time student status. The partnership allows Benefit Express clients to validate the full-time student status of all dependents at more than 2,400 accredited colleges and universities in the United States, representing more than 80% of U.S. total enrollment electronically.

20 Oct 2009

Investment opportunities in the global patient monitoring market thru 2015

MarketResearch.com has announced the addition of Global Markets Direct's new report "Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015," to their collection of Patient Monitoring market reports.

20 Oct 2009

NicOx presents data on its phase 3 naproxcinod study at the ACR meeting

NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.

20 Oct 2009

Philips launches DirectLife fitness program to deliver health benefits

Philips is delivering on their commitment to be the leader in health and well-being with the launch of Philips DirectLife, a new customized, interactive fitness program that offers a fun and simple solution to people eager to adopt a more active lifestyle.

20 Oct 2009

Family structure does not impact adolescents' behaviors

The conventional family has changed over the past decade. According to a new study by the Working Group on Adolescence of the Andalusian Society of Family and Community Medicine, which has been published in the Spanish journal Atenci-n Primaria, adolescents' perception of proper family functioning has little to do with the traditional nuclear structure.

20 Oct 2009

Patheon, Lonza Group mutually agree to terminate discussions

The Special Committee of Independent Directors of Patheon Inc. today announced that Lonza Group AG ("Lonza") has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of the Company. In addition, the Special Committee and Lonza have mutually agreed to terminate discussions regarding other possible strategic transactions between Lonza and Patheon.

20 Oct 2009

Rexahn Pharmaceuticals announces positive results from Phase IIa Serdaxin clinical study

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in CNS and oncology, today announced top-line results from a Phase IIa clinical study of Serdaxin™, its major depressive disorder (MDD) drug candidate.

20 Oct 2009

Medical News

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Springer to launch "Translational Stroke Research" journal

Age, gender and malignancies pose significant risk factors for TIVADs survival

Unemployment for people with disabilities has reached its highest rate since January, says study

ECRI Institute reports increase in request for medical technology acquisition support from its members

Academic medical centers do not always practice the values they preach

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

OHA announces its selection as one of Greater Toronto's Top 90 Employers for 2010

Higher status positions can have negative impact on personal health

Study explores the link between LUTS and depression, anxiety disorders, sexual trauma

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

UHC selects RGIS to streamline inventory counting services

Benefit Express collaborates with National Student Clearinghouse for student status verification services

Investment opportunities in the global patient monitoring market thru 2015

NicOx presents data on its phase 3 naproxcinod study at the ACR meeting

Philips launches DirectLife fitness program to deliver health benefits

Family structure does not impact adolescents' behaviors

Patheon, Lonza Group mutually agree to terminate discussions

Rexahn Pharmaceuticals announces positive results from Phase IIa Serdaxin clinical study

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News